Clinical Trials
Closed
Phase
Accrual
93%
SWOG Clinical Trial Number
SWOG-703
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
SWOG-226
Phase II Protocol for Porfiromycin Solid Tumors
Activated
07-12-1967
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
SWOG-427
Cytosine Arabinoside (NSC-63878) in Acute Leukemia in Adults
Activated
07-01-1967
Closed
06-09-1969
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8264
Combination Chemotherapy with m-AMSA, Cis-Platinum and MGBG for Refractory Lymphoma
Activated
08-11-1962
Closed
03-16-1984
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-200
Closed
Phase
SWOG Clinical Trial Number
SWOG-8570
Treatment of Brain Tumors With Intra-Arterial Cis-Platinum and BCNU
Closed
04-15-1987
Closed
Phase
SWOG Clinical Trial Number
SWOG-9001
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8530
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8276
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
SWOG-425/426
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8510
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
SLA01
CHARACTERIZATION OF THE EXPRESSION OF IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES
Research Committee(s)
Gastrointestinal Cancer